Lynn Seely Lyell Immunopharma, Inc. (LYEL) insider trading activity
Lynn Seely is President and CEO of Lyell Immunopharma, Inc.. Currently has a direct ownership of 34,828 shares of LYEL, which is worth approximately $368,131. The most recent transaction as insider was on Aug 12, 2025, when has been sold 406 shares (Common Stock) at a price of $10.34 per share, resulting in proceeds of $4,198. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).
Shares Held (Direct Ownership)
34.8K
95.11%
3M change
82.59%
12M change
Total Value Held
$368,131
Lynn Seely Transaction History
Also insider at
LS
Lynn Seely
President and CEO
Cambridge, MA